PositiveID Announces Medical Device Subsidiary 2018 Trade Show Schedule

DELRAY BEACH, Fla., Feb. 28, 2018 -- Diversified life sciences company, PositiveID Corporation (OTC:PSID), today announced the list of 2018 trade shows its wholly owned, professional-grade thermometer subsidiary Thermomedics plans to attend.

Thermomedics’ mission is to establish its Caregiver® thermometer as a healthcare standard due to the cost savings and reduced cross contamination enabled by its non-contact, plastic cover-free features.  Single-use, plastic covers cost up to $.10 per unit with millions consumed in the U.S. annually.

The latest version of Caregiver is Bluetooth®-enabled allowing automatic entry of temperature readings into patient records and better patient care from improved monitoring.

“We intend to capitalize on the increasing vigilance against instrument contamination as well as improved treatment arising from medical record digitization by expanding our marketing,” commented William J. Caragol, PositiveID Chairman and CEO.

In addition to the Company’s Feb 21-23 exhibit at the Journal of Emergency Medical Services (JEMS) Conference and Exposition, Thermomedics plans to attend the following trade events in 2018:    

ABOUT POSITIVEID
PositiveID Corporation is a holding company focused on life sciences, diagnostics, medical devices, and mobile laboratories. PositiveID's ExcitePCR subsidiary is developing the FireflyDX family of pathogen detection systems, portable devices offering rapid sample-to-result detection in less than 30 minutes using real-time polymerase chain reaction chemistry. PositiveID's E-N-G Mobile Systems™ subsidiary is a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. PositiveID's Thermomedics subsidiary markets the FDA-cleared Caregiver® non-contact thermometer for clinical use. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.

SAFE HARBOR
Statements about PositiveID's future expectations, including the likelihood that the Company plans to accelerate sales of new Bluetooth®-enabled, non-contact Caregiver thermometer; the likelihood that the Company will attend the list of 2018 trade shows; the likelihood that the Company intends to capitalize on the increasing vigilance against instrument contamination as well as improved treatment arising from medical record digitization by expanding its marketing; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to target the professional healthcare market; the Company’s ability to raise capital; as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 31, 2017, and 10-Qs filed on November 13, 2017, August 14, 2017, and May 15, 2017, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Contact:
PositiveID Corporation
Allison Tomek
(561) 805-8044